Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1030463

Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab


Barešić, Marko; Reihl, Mirna; Habek, Mario; Vukojević, Nenad; Anić, Branimir
Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab // Rheumatology International, 38 (2018), 7; 1301-1306 doi:10.1007/s00296-018-4054-9 (recenziran, članak, znanstveni)


CROSBI ID: 1030463 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab
(Improvement of neurological and ocular symptoms of Behçet’s disease after the introduction of infliximab)

Autori
Barešić, Marko ; Reihl, Mirna ; Habek, Mario ; Vukojević, Nenad ; Anić, Branimir

Izvornik
Rheumatology International (0172-8172) 38 (2018), 7; 1301-1306

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Behçet’s disease ; Glucocorticoids ; Infliximab ; Neurologic and ocular involvement

Sažetak
Behçet's disease is a chronic inflammatory condition of unknown origin characterized by multiple organ involvement. The most common symptoms of Behçet's disease are recurrent oral and/or genital ulcerations in combination with symptoms affecting eyes, skin, central and peripheral nervous system, blood vessels and gastrointestinal tract. We present a 43-year-old female patient with the history of recurrent episodes of genital and oral ulcerations, elevated acute phase reactants and skin lesions. The diagnosis of Behçet's disease has been delayed (for more than 10 years) and reached only after she developed neurological and ocular symptoms. Treatment with glucocorticoids and azathioprine was partially successful. High doses of glucocorticoids were needed to control the disease and cyclosporine A was nephrotoxic. Remission was reached after the introduction of infliximab (plus methotrexate) and glucocorticoids were stopped. In the recent years, infliximab has been accepted as a standard therapy for refractory cases of Behçet's disease (neurological, ocular or gastrointestinal). Our patient presented with refractory ocular and neurological symptoms and infliximab was effective for both manifestations. Long-term side-effects of glucocorticoids and other immunosuppressants can be avoided with TNF-α blockade. We emphasize the importance of a timely and accurate diagnosis and significance of excluding more common diseases in a work-up algorithm

Izvorni jezik
Engleski



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Marko Barešić (autor)

Avatar Url Nenad Vukojević (autor)

Avatar Url Branimir Anić (autor)

Avatar Url Mario Habek (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Barešić, Marko; Reihl, Mirna; Habek, Mario; Vukojević, Nenad; Anić, Branimir
Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab // Rheumatology International, 38 (2018), 7; 1301-1306 doi:10.1007/s00296-018-4054-9 (recenziran, članak, znanstveni)
Barešić, M., Reihl, M., Habek, M., Vukojević, N. & Anić, B. (2018) Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab. Rheumatology International, 38 (7), 1301-1306 doi:10.1007/s00296-018-4054-9.
@article{article, author = {Bare\v{s}i\'{c}, Marko and Reihl, Mirna and Habek, Mario and Vukojevi\'{c}, Nenad and Ani\'{c}, Branimir}, year = {2018}, pages = {1301-1306}, DOI = {10.1007/s00296-018-4054-9}, keywords = {Beh\c{c}et’s disease, Glucocorticoids, Infliximab, Neurologic and ocular involvement}, journal = {Rheumatology International}, doi = {10.1007/s00296-018-4054-9}, volume = {38}, number = {7}, issn = {0172-8172}, title = {Improvement of neurological and ocular symptoms of Beh\c{c}et's disease after the introduction of infliximab}, keyword = {Beh\c{c}et’s disease, Glucocorticoids, Infliximab, Neurologic and ocular involvement} }
@article{article, author = {Bare\v{s}i\'{c}, Marko and Reihl, Mirna and Habek, Mario and Vukojevi\'{c}, Nenad and Ani\'{c}, Branimir}, year = {2018}, pages = {1301-1306}, DOI = {10.1007/s00296-018-4054-9}, keywords = {Beh\c{c}et’s disease, Glucocorticoids, Infliximab, Neurologic and ocular involvement}, journal = {Rheumatology International}, doi = {10.1007/s00296-018-4054-9}, volume = {38}, number = {7}, issn = {0172-8172}, title = {Improvement of neurological and ocular symptoms of Beh\c{c}et’s disease after the introduction of infliximab}, keyword = {Beh\c{c}et’s disease, Glucocorticoids, Infliximab, Neurologic and ocular involvement} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font